Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 13/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19796931 | 0.94 | SPHK1 (0.35) | SPHK1TSHRCA1CA2 | |
| SCHEMBL19007873 | 0.94 | ACE2 (0.35) | SPHK1CYP2C9TSHRCA1CA2 | |
| SCHEMBL19797085 | 0.93 | SPHK1 (0.38) | SPHK1FFAR4CYP2C9TSHRSPHK2 | |
| SCHEMBL19797111 | 0.93 | SPHK1 (0.38) | SPHK1FFAR4CYP2C9TSHRSPHK2 | |
| SCHEMBL19797087 | 0.90 | SPHK1 (0.37) | SPHK1FFAR4CYP2C9TSHRSPHK2 | |
| SCHEMBL19007871 | 0.90 | CA1 (0.35) | SPHK1CYP2C9TSHRCA1CA2 | |
| SCHEMBL19796810 | 0.89 | SPHK1 (0.37) | SPHK1FFAR4CYP2C9TSHRCA1 | |
| SCHEMBL19796609 | 0.88 | CNR2 (0.38) | CYP2C9TSHRCA1CA2 | |
| SCHEMBL19804782 | 0.87 | FFAR4 (0.40) | FFAR4CYP2C9CA1CA2 | |
| SCHEMBL19796651 | 0.87 | FPR2 (0.36) | CYP2C9TSHRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | SPHK1 608/4885FFAR4 1715/4885CYP2C9 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.